Back
Challenges for mesenchymal stromal cell therapies.
Journal article

Challenges for mesenchymal stromal cell therapies.

  • Martin I Department of Biomedicine, University Hospital Basel, University of Basel, 4031 Basel, Switzerland. ivan.martin@usb.ch.
  • Galipeau J Department of Medicine, University of Wisconsin Carbone Comprehensive Cancer Center, Madison, WI 53715, USA.
  • Kessler C Health Directorate, Directorate General for Research and Innovation, European Commission, 1049 Brussels, Belgium.
  • Le Blanc K Center for Hematology and Regenerative Medicine, Karolinska University Hospital, 171 77 Stockholm, Sweden.
  • Dazzi F School of Cancer and Pharmacological Sciences, King's Health Partners Cancer Research UK Centre, King's College London, London SE1 9NH, UK.
  • 2019-02-22
Published in:
  • Science translational medicine. - 2019
Animals
Clinical Trials as Topic
Humans
Immunomodulation
Mesenchymal Stem Cell Transplantation
Mesenchymal Stem Cells
English Clinical trials of mesenchymal stromal cell therapies reveal a challenging heterogeneous landscape, including diverse therapeutic targets, patient categories, cell sources, and potential mechanisms of action.
Language
  • English
Open access status
closed
Identifiers
Persistent URL
https://sonar.ch/global/documents/124846
Statistics
Document views: 72 File downloads: